Diazyme Gets CE-IVD for Semi-Quantitative SARS-CoV-2 Neutralizing Antibody Test
The high-throughput chemiluminescent immunoassay has been used to evaluate the adaptive immune response in vaccine studies.
Read More
Search Results for: covid-19
First Hybridization Capture-Based NGS Covid-19 Assay Gets FDA EUA
The hybridization capture-based approach utilized in this assay from Twist Bioscience and Biotia maximizes the number of genetic variants identified, where other sequencing methods may miss mutations in certain regions.
Read More
FDA Posts Info on Viral Mutations’ Impact on Covid-19 Tests
FDA has created a page on its website devoted to providing information about the impact of SARS-CoV-2 viral mutations on covid-19 tests, including recommendations for clinical laboratory staff.
Read More
Leinco Technologies, La Jolla Institute for Immunology to Develop Novel Covid-19 Diagnostic Tools
Leinco will gain exclusive access to certain SARS-CoV-2 antibodies directed against the virus’ N protein and make the antibodies commercially available.
Read More
Acupath Guarantees 24-Hour In-Lab Turnaround Time for Covid-19 PCR Results
Acupath Laboratories will meet covid-19 PCR in-lab turnaround time of 24 hours or less for all electronically ordering direct bill customers, or the test fee will be waived.
Read More